Zsa Zsa Weerts

Chapter 9 230 Symptom Journal Smartphone App. Clin Transl Gastroenterol 2016;7:e147. 23. Lackner JM, Jaccard J, Keefer L, et al. Improvement in Gastrointestinal Symptoms After Cognitive Behavior Therapy for Refractory Irritable Bowel Syndrome. Gastroenterology 2018;155: 47-57. 24. Aaron LA, Mancl L, Turner JA, et al. Reasons for missing interviews in the daily electronic assessment of pain, mood, and stress. Pain 2004;109:389-398. 25. Arntz R, Wilmots J, de Rooij J, et al. Voor wie Nederland en Vlaanderen wil leren kennen: Diepenbeek: Wetenschappelijk Onderwijs Limburg, 1978. 26. de Jonge H. Ons soort mensen levensstijlen in Nederland 1997. 27. Wood CW. The History of the Low Countries, History: Reviews of New Books. 1999;28:29-30. 28. Lembo A, Lacy B, Zuckerman M, et al. Eluxadoline for Irritable Bowel Syndrome with Diarrhea. N Engl J Med 2016; 374:242-253. 29. Pimentel M, Lembo A, Chey WD, et al. Rifaximin therapy for patients with irritable bowel syndrome without constipation. N Engl J Med 2011;364:22-32. 30. Rao S, Lembo A, Shiff S, et al. A 12-week, randomized, controlled trial with a 4-week randomized withdrawal period to evaluate the efficacy and safety of linaclotide in irritable bowel syndrome with constipation. Am J Gastroenterol 2012;107:1714-1724. 31. Chey WD, Lembo AJ, Rosenbaum DP. Efficacy of Tenapanor in Treating Patients With Irritable Bowel Syndrome With Constipation: A 12-Week, Placebo- Controlled Phase 3 Trial (T3MPO-1). Am J Gastroenterol 2020;115:281-293. 32. Abu-Hasaballah K, James A, Aseltine RH Jr. Lessons and pitfalls of interactive voice response in medical research. Contemp Clin Trials 2007;28:593-602.

RkJQdWJsaXNoZXIy ODAyMDc0